Micronized Purified Flavonoid Fraction (MPFF) for Patients suffering from Chronic Venous Disease (CVD)

Chronic Venous Disease (CVD) is both prevalent and unavoidable in many people because of persistent or unalterable risk factors, the most important of which are advanced age, excess body weight, and family history. Given this inevitability, medical treatment is required to alleviate symptoms and slow disease progression

Venoactive drug therapy is emerging as a valuable treatment option for many Chronic Venous Disease (CVD) patients and Micronized Purified Flavonoid Fraction (MPFF) is the most widely prescribed and well-studied venoactive drug available. Recent evidence from animal models of venous hypertension and from clinical trials, as well as from systematic reviews, shows that

Micronized Purified Flavonoid Fraction (MPFF) is effective at alleviating many of the most common symptoms of Chronic Venous Disease (CVD) including leg pain, leg heaviness, sensations of swelling, cramps, and functional discomfort.

In addition, Micronized Purified Flavonoid Fraction (MPFF) improves the clinical signs of redness, skin changes, and edema, and improves quality of life. Collectively, these findings support the strong recommendation for Micronized Purified Flavonoid Fraction (MPFF) treatment found in the 2018 international guidelines for the management of Chronic Venous Disease (CVD)

Source: Jorge H Ulloa, Adv Ther. 2019 Mar;36(Suppl 1):20-25. doi: 10.1007/s12325-019-0884-4. Epub 2019 Feb 13.

To know more : Click here